• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Betistine
    / Rafa


    Active Ingredient
    Betahistine (as HCl) 16 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    30 X 16 mg

    not in the basket chart 27298 2271

    Related information


    Dosage

    Initial: 8-16 mg 3 times a day.
    Maintenance: 24-48 mg daily.


    Indications

    Meniere’s syndrome characterized by vertigo and tinnitus and/or hearing impairment. Symptomatic treatment of peripheral vertigo.


    Contra-Indications

    Hypersensitivity, patients with pheochromocytoma.


    Special Precautions

    Asthma, peptic ulcer, not to be given concomitantly with antihistamines. Pregnancy and lactation.


    Drug interactions

    Antihistamines.


    Manufacturer
    Rafa Laboratories Ltd.
    CLOSE